Related Experiment Video

Updated: Jun 25, 2026

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models
05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands,

Andrew E Aplin1, Katherina Alsina2, Allison S Betof3

  • 1Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University and Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania, USA.

Pigment Cell & Melanoma Research
|June 24, 2026
PubMed

Insights

The 2025 Cure Ocular Melanoma meeting highlighted the need for improved uveal melanoma prevention, detection, and treatment. International collaboration is key to advancing drug candidates and patient care for this rare cancer.

Area of Science:

  • Ophthalmology
  • Oncology
  • Medical Research

Background:

  • Uveal melanoma is a rare but aggressive eye cancer.
  • Current treatment options for uveal melanoma are limited.
  • There is an urgent need for advancements in prevention, detection, and treatment strategies.

Purpose of the Study:

  • To foster international collaboration among scientists, industry stakeholders, and patient advocates.
  • To facilitate the exchange of ideas and research findings in ocular melanoma.
  • To accelerate the development of novel therapeutic approaches for uveal melanoma.

Main Methods:

  • The 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting convened experts in the field.
  • Discussions focused on current research, challenges, and future directions in uveal melanoma.
  • The meeting aimed to identify promising drug candidates and therapeutic strategies.

Main Results:

  • Several promising drug candidates for uveal melanoma are currently in development.
  • The meeting underscored the critical need for enhanced prevention and early detection methods.
  • International collaboration was identified as crucial for overcoming research hurdles.

Conclusions:

  • Continued international collaboration is essential for advancing uveal melanoma research.
  • Further development of targeted therapies and diagnostic tools is required.
  • Improving patient outcomes for uveal melanoma necessitates a multi-faceted approach involving research, industry, and patient advocacy.

More Related Videos

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...